DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

29.49 -0.42 (-1.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $29.49 -1.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.01
Previous Close $29.91
Daily Range $28.56 - $30.20
52-Week Range $11.33 - $33.16
Market Cap $1.2B
P/E Ratio -8.43
Dividend (Yield) $0.00 (0.0%)
Volume 763,707
Average Daily Volume 1,402,704
Current FY EPS -$4.92

Sector

Healthcare

Industry

Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sarepta.com/

News & Commentary

The Drug Development Process Explained in Detail and How It Impacts Your Investments

A detailed step-by-step guide on how a drug goes from a concept in the lab to a product on pharmacy shelves, and how the drug development process can affect your investments.

Catabasis Up on Fast Track Status for DMD Drug CAT-1004 - Analyst Blog

Several Biotech Stocks Indicating A Macro Short Strategy

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Pre

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Press Releases

Cramer Is Flying Southwest, Won't Recommend Sarepta Therapeutics

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Ana

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

Sarepta Therapeutics (SRPT) Showing Signs Of Perilous Reversal Today

Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog

BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog

5 Biotech Stocks On Deck With The FDA

Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT)

See More SRPT News...

SRPT's Top Competitors

SRPT $29.49 (-1.40%)
Current stock: SRPT
AMGN $155.39 (0.58%)
Current stock: AMGN
GILD $115.13 (-0.46%)
Current stock: GILD
BIIB $408.06 (0.85%)
Current stock: BIIB